SCHEMBL8395652

SCHEMBL8395652

CNC(=S)NC1CCCCC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.73
ALDH1A1 P00352 2/20 0.73
TP53 P04637 1/20 0.73
SMN1; SMN2 Q16637 4/20 0.65
LMNA P02545 2/20 0.61
GAA P10253 2/20 0.61
HTT P42858 1/20 0.52
PKM P14618 1/20 0.52
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ALOX12 P18054 1/20 0.49
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 1/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 2/20 0.48
MAPK1 P28482 1/20 0.48
DUSP3 P51452 1/20 0.48
PTPN5 P54829 1/20 0.48
PTPN11 Q06124 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19705886 1.00 CYP3A4 (0.73) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL19705885 1.00 CYP3A4 (0.73) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL26940074 1.00 CYP3A4 (0.73) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL19705884 1.00 CYP3A4 (0.73) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL7928146 1.00 CYP3A4 (0.73) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL19705995 1.00 CYP3A4 (0.73) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL14564699 0.98 CYP3A4 (0.68) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL8396968 0.93
SCHEMBL23591881 0.88 CYP3A4 (0.57) CYP3A4ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL1544580 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115089569-A Use of bipolar trans carotenoids in conjunction with chemotherapy and radiation therapy for the treatment of cancer 扩散药品有限公司 2022-09-23 CN disclosed
EP-3519467-B1 BIS-PHOSPHAGUANIDINE AND POLY-PHOSPHAGUANIDINE LIGANDS WITH GROUP IV METAL CATALYSTS PRODUCED THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2021-03-17 EP disclosed
US-5864043-A CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST KARL THOMAE GMBH (DE) 1999-01-26 US disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 US disclosed
US-4125614-A DIURETIC HOECHST AKTIENGESELLSCHAFT (DE) 1978-11-14 US disclosed
US-4083979-A Thiazolidine derivatives and their use as salidiuretics HOECHST AKTIENGESELLSCHAFT (DT) 1978-04-11 US disclosed
US-4061647-A DIURETICS HOECHST AKTIENGESELLSCHAFT (DT) 1977-12-06 US disclosed
US-4061761-A Thiazolidine derivatives HOECHST AKTIENGESELLSCHAFT (DT) 1977-12-06 US disclosed
US-4053299-A NOVEL THIOTRIAZINEDIONES AND THEIR USE AS HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-10-11 US disclosed
US-4049710-A Novel carbamimidoyl chlorides and their use in the synthesis of herbicidal triazinediones E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-09-20 US disclosed